Target intelligence / Profile preview

Host sialic acid-containing glycan receptors (SA-glycans)

Target
SA-glycans
Molecular classification
Glycan, Carbohydrate, Receptor
01

Overview

Host sialic acid-containing glycan receptors are complex carbohydrate structures located on the terminal ends of glycoproteins and glycolipids on the surface of vertebrate cells. These glycans, primarily composed of N-acetylneuraminic acid (Neu5Ac), serve as critical mediators for various physiological processes, including cell-cell adhesion, immune system regulation, and signal transduction. However, they are also frequently exploited by a wide range of pathogens, such as influenza viruses, parainfluenza viruses, and certain bacteria, as primary attachment points for host cell entry. The specific linkage of the sialic acid (e.g., α2,3 or α2,6) is a major determinant of host range and tissue tropism, particularly for respiratory viruses. Therapeutic interventions targeting these receptors often involve the use of sialidases (like DAS181) to enzymatically remove the sialic acid residues, thereby stripping the cell of the 'doorway' used by viruses, or the use of neuraminidase inhibitors to prevent the release of newly formed viral particles from these glycan anchors.

Other names
Sialylated glycansSialic acid receptorsSialosidesN-acetylneuraminic acid-containing glycansNeu5Ac-containing glycansSialic acid-terminated glycoconjugates
02

Mechanism of action

Enzymatic cleavage of terminal sialic acid residues to prevent viral attachment; competitive inhibition of viral neuraminidase to prevent viral release; blocking of pathogen hemagglutinin binding sites.

03

Biological functions

Cell-cell recognitionCell adhesionImmune response modulationSignal transductionProtein stabilityPathogen attachment site
04

Disease associations

InfectionInfluenzaCancer metastasisInflammationViral entry
05

Safety considerations

Disruption of normal host cell signalingPotential for pro-inflammatory responsesOff-target effects on immune cell traffickingTransient nature of enzymatic receptor removal
06

Interacting drugs

DAS181

5 more in the full profile.

07

Biomarkers

Alpha 2,3-linked sialic acid expressionAlpha 2,6-linked sialic acid expressionSialyl-Lewis X antigenTotal serum sialic acid

Beyond the preview

Go deeper on Host sialic acid-containing glycan receptors (SA-glycans).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host sialic acid-containing glycan receptors (SA-glycans).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call